Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes	Abdominal Pain, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Flatulence, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, connective tissue disorder, constipation disorder, cutaneous mucinosis, diarrheal disease, digestive system disorder, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4	Active, not recruiting	Not applicable	2026-04-01		NCT07408518

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
People Science, Inc.	15
Synbiotic Health	3

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
People Science, Inc.	Los Angeles	United States	3